M&A Deal Summary

EQT Private Capital Asia Acquires Lumenis

On November 19, 2019, private equity firm EQT Private Capital Asia acquired medical products company Lumenis from XIO Group for 1.0B USD

Acquisition Highlights
  • This is EQT Private Capital Asia’s 2nd transaction in the Medical Products sector.
  • This is EQT Private Capital Asia’s 14th largest (disclosed) transaction.
  • This is EQT Private Capital Asia’s 1st transaction in Israel.

M&A Deal Summary

Date 2019-11-19
Target Lumenis
Sector Medical Products
Buyer(s) EQT Private Capital Asia
Sellers(s) XIO Group
Deal Type Secondary Buyout
Deal Value 1.0B USD

Target

Lumenis

Yokneam, Israel
Lumenis is a medical company for surgical, ophthalmology and aesthetic appliances & equipment. Lumenis was founded in 1991 and is based in Yokneam, Isreal.

Search 208,737 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

EQT Private Capital Asia

Hong Kong, China

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1997
PE ASSETS 125.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

EQT Private Capital Asia is an Asia-focused private equity group specializing in growth equity investments and buyouts of companies valued between $300 million and $1.5 billion. Baring looks for companies that require capital for organic expansion, recapitalizations, or to fund acquisitions. The Group's geographic coverage spans China, India, Japan, Singapore, Hong Kong, and Taiwan. EQT Private Capital Asia was formed in 1997 and is based in Hong Kong.


DEAL STATS #
Overall 46 of 69
Sector: Medical Products M&A 2 of 4
Type: Secondary Buyout M&A Deals 11 of 16
Country: Israel M&A 1 of 1
Year: 2019 M&A 5 of 5
Size (of disclosed) 14 of 21
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-11-18 VUS

Ho Chi Minh City, Vietnam

VUS provides english language training (ELT) with millions of learners enrolling for its courses since its foundation. VUS is based in Ho Chi Minh City, Vietnam.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2020-06-25 HUTCHMED

Hong Kong, China

HUTCHMED is an innovative, commercial-stage biopharmaceutical company committed to the discovery and global development of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. HUTCHMED was founded in 2000 and is based in Hong Kong, China.

Buy -

Seller(S) 1

SELLER
DESCRIPTION

Xio Group is an alternative investment firm focused on investing in and growing market-leading and high-performing businesses located across Europe and North America. The Firm looks to partner with management to help these companies expand into new markets, particularly China. Xio Group was formed in 2014 and is based in London.


DEAL STATS #
Overall 3 of 3
Sector: Medical Products M&A 1 of 1
Type: Secondary Buyout M&A Deals 2 of 2
Country: Israel M&A 1 of 1
Year: 2019 M&A 2 of 2
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2019-07-30 J.D. Power

Westlake Village, California, United States

J.D. Power is a marketing information services company providing performance improvement, social media, and customer satisfaction insights and solutions. J.D. Power was founded in 1968 and is based in Westlake Village, California.

Sell -